
Omlar-CV 250mg/50mg Injection
Marketer
Stellar Bio-Labs
Salt Composition
Amoxycillin (250mg) + Clavulanic Acid (50mg)
Overview Omlar-CV 250mg/50mg Injection
Omlar-CV 250mg/50mg Injection, a penicillin-based antibiotic, combats bacterial infections. It's indicated for treating infections affecting the lungs (like pneumonia), ears, sinuses, urinary tract, skin, and soft tissues. It's ineffective against viral illnesses such as the common cold. Administration is strictly by a healthcare provider; self-injection is prohibited. Dosage and frequency are determined by your physician based on your condition's severity, always adhering to their prescribed regimen. Typical side effects may include nausea, vomiting, diarrhea, oral thrush, and localized injection site reactions (pain, swelling, redness). Persistent or worsening side effects require medical attention. Patients with impaired liver or kidney function should consult their doctor before initiating treatment. Prior to use, disclose any antibiotic allergies or pre-existing kidney or liver conditions; adjustments to dosage or alternative medications may be necessary. Under medical supervision, this injection is generally considered safe for use during pregnancy and breastfeeding.
Uses of Omlar-CV 250mg/50mg Injection
Preventing bacterial infections related to surgical procedures
Major Benefits of Omlar-CV 250mg/50mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
Common Side effects of Omlar-CV 250mg/50mg Injection:
- Vomiting
- Nausea
- Diarrhea
- Thrush
How to use Omlar-CV 250mg/50mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Omlar-CV 250mg/50mg Injection works:
Omlar-CV Injection (250mg/50mg) combines amoxicillin, a bacterial growth inhibitor, with clavulanate potassium, a beta-lactamase inhibitor. Amoxicillin disrupts bacterial cell wall synthesis, compromising bacterial survival. Clavulanate potassium counteracts bacterial resistance mechanisms, thus boosting amoxicillin's effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse interactions between Omlar-CV 250mg/50mg Injection and alcohol consumption.
PregnancySAFE IF PRESCRIBED
The injectable medication Omlar-CV (250mg/50mg) is typically deemed safe for use during pregnancy. Preclinical trials in animals revealed minimal or no harmful effects on fetal development; nonetheless, clinical data from human trials remain scarce.
Breast feedingSAFE IF PRESCRIBED
The medication Omlar-CV 250mg/50mg Injection presents a low risk during lactation. Research in humans indicates minimal drug transfer into breast milk, posing no discernible threat to the infant.
DrivingUNSAFE
Administering Omlar-CV 250mg/50mg Injection might result in adverse reactions impacting driving capabilities. These reactions can include allergic responses, vertigo, or seizures, rendering operation of a vehicle unsafe.
KidneyCAUTION
The administration of Omlar-CV 250mg/50mg Injection requires careful monitoring in individuals with impaired renal function. Dosage modification of Omlar-CV 250mg/50mg Injection might be necessary. Physician consultation is advised. This medication is contraindicated in patients exhibiting severe kidney impairment.
LiverCAUTION
Patients with liver impairment should exercise caution when using Omlar-CV 250mg/50mg Injection, as dosage modification may be necessary. Medical advice is recommended. Consistent monitoring of liver function is advised during treatment.
What if you forget to take Omlar-CV 250mg/50mg Injection :
Should you forget a dose of Omlar-CV 250mg/50mg Injection, administer it at your earliest convenience. However, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Omlar-CV 250mg/50mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
